Wilkening J, Schwandt P
Horm Metab Res. 1977 Mar;9(2):132-6. doi: 10.1055/s-0028-1093561.
The influence of clofibrate on the glycolytic pathway in liver was studied. The changes in the activity of glucokinase and hexokinase were not significant. A reduction of phosphofructokinase (p less than 0.05) and pyruvate kinase activity was found (p less than 0.0005) during clofibrate feeding. An in vitro inhibition of these enzymes could not be demonstrated by clofibrate up to a concentration of 2.5 mM. Crossover plots of glycolytic intermediates indicate that the reduced pyruvate kinase activity may influence the glycolytic pathway in vivo. Clofibrate feeding induces a lower ATP:ADP ratio, a lower adenylate energy charge and elevates AMP levels in rat liver. This may possibly stimulate the hepatic glycogenolysis and the glucose utilisation by this organ.
研究了氯贝丁酯对肝脏糖酵解途径的影响。葡萄糖激酶和己糖激酶活性的变化不显著。在给予氯贝丁酯期间,发现磷酸果糖激酶活性降低(p<0.05),丙酮酸激酶活性降低(p<0.0005)。在高达2.5 mM的浓度下,氯贝丁酯未显示出对这些酶的体外抑制作用。糖酵解中间产物的交叉图表明,丙酮酸激酶活性降低可能会在体内影响糖酵解途径。给予氯贝丁酯会导致大鼠肝脏中ATP:ADP比值降低、腺苷酸能量电荷降低以及AMP水平升高。这可能会刺激该器官的肝糖原分解和葡萄糖利用。